What are the guidelines for annual wellness screenings in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Annual Wellness Screening Guidelines for Adults

Adults should receive risk-stratified preventive screenings based on age, with blood pressure checked at every visit, cardiovascular risk assessment beginning at age 35-45, cancer screenings initiated between ages 21-50 depending on the specific cancer, and diabetes screening for those aged 40-70 years who are overweight or obese. 1

Cardiovascular Screening

Blood Pressure:

  • Screen all adults at every clinical visit regardless of age 2
  • Annual screening for high-risk individuals (African American, high-normal blood pressure, obese/overweight, age >40 years) 1
  • Screen every 3-5 years for low-risk adults aged 18-39 years with no risk factors 1
  • Confirm hypertension diagnosis outside the clinical setting before initiating treatment 1

Lipid Screening:

  • Begin screening men at age 35 and women at age 45 3
  • Measure total cholesterol and HDL cholesterol 3
  • Non-fasting samples are acceptable 3
  • Repeat every 5 years for average-risk individuals 3
  • Consider more frequent screening (annually or every 6-12 months) as patients approach age 40 2

Diabetes Screening

  • Screen adults aged 40-70 years who are overweight or obese (BMI ≥25 kg/m²) 1
  • Use hemoglobin A1C or fasting glucose 2
  • Refer patients with abnormal glucose to intensive behavioral counseling 1
  • Screen earlier if additional risk factors present (family history, sedentary lifestyle) 3

Cancer Screening

Colorectal Cancer:

  • Begin screening at age 45 for all average-risk adults 1, 2
  • Continue through age 75 in adults with good health and life expectancy >10 years 1
  • Screening options include:
    • Annual fecal immunochemical test (FIT) 1
    • Colonoscopy every 10 years 1
    • CT colonography every 5 years 1
    • Flexible sigmoidoscopy every 5 years 1
    • Multitarget stool DNA test every 3 years 1
  • All positive non-colonoscopy tests require timely colonoscopy follow-up 1
  • Ages 76-85: individualize based on patient preferences, life expectancy, health status, and prior screening history 1
  • Age >85: discourage continued screening 1

Breast Cancer (Women):

  • Women aged 40-44 may begin annual mammography if they choose 1
  • Women aged 45-54 should undergo annual mammography 1
  • Women aged ≥55 should transition to biennial screening or continue annually based on preference 1, 4
  • Continue screening as long as overall health is good and life expectancy ≥10 years 1, 4
  • Clinical breast examination every 3 years for ages 20-39, then annually starting at age 40 3

Cervical Cancer (Women):

  • Begin screening at age 21 1, 4
  • Ages 21-29: Pap test every 3 years 1
  • Ages 30-65: HPV test plus Pap test every 5 years (preferred) OR Pap test alone every 3 years (acceptable) 1
  • Stop screening at age >65 if ≥3 consecutive negative Pap tests OR ≥2 consecutive negative HPV+Pap tests within the last 10 years, with most recent test within last 5 years 1, 4
  • Stop screening after total hysterectomy 1
  • New sexual partners do NOT restart screening after age 65 4

Lung Cancer:

  • Screen adults aged 55-74 (or 55-80 per some guidelines) with low-dose CT annually 1, 2, 4
  • Eligibility criteria:
    • ≥30 pack-year smoking history 1, 2, 4
    • Currently smoke OR quit within past 15 years 1, 2, 4
    • Must receive smoking cessation counseling if current smoker 1
    • Requires informed/shared decision-making discussion 1
    • Access to high-volume, high-quality screening and treatment center 1

Prostate Cancer (Men):

  • Begin shared decision-making discussion at age 50 for men with ≥10-year life expectancy 1, 3
  • Higher-risk men (African descent, first-degree relative diagnosed before age 65) should begin discussion at age 45 3
  • Screening involves PSA testing with or without digital rectal examination 1, 3
  • Do not screen without informed decision-making process 1

Sexually Transmitted Infection Screening

Chlamydia and Gonorrhea:

  • Screen all sexually active women younger than 25 years (not ≤25) 1, 5
  • Screen older women at increased risk 5
  • Among women aged 15-24 with opposite-sex partners in past year, only 37.5% were tested for chlamydia 6

HIV:

  • Screen all patients aged 15-65 years regardless of risk 5
  • Screen younger and older patients at increased risk 5
  • All pregnant women should be tested 5

Hepatitis C:

  • Screen persons at increased risk 5
  • Test persons with HIV infection at least annually 1

Syphilis and Hepatitis B:

  • Screen persons at increased risk 5
  • All pregnant women should be tested 5

Additional Preventive Services

Endometrial Cancer:

  • No routine screening for average-risk women 3
  • At menopause, inform women about risks and symptoms; encourage reporting of unexpected bleeding or spotting 1
  • Any postmenopausal bleeding warrants prompt investigation 4

Osteoporosis:

  • Evaluate risk factors: smoking, low body weight, chronic glucocorticoid use, excess alcohol 4
  • Consider bone-density testing even before age 65 in high-risk individuals 4

Immunizations:

  • Annual influenza vaccine 2, 4
  • Pneumococcal vaccines (PPSV23 and PCV13 when indicated) 4
  • Recombinant herpes-zoster vaccine 4
  • Tetanus every 10 years 2
  • HPV vaccine for appropriate age groups 7

Common Pitfalls

  • Do not continue cervical cancer screening after age 65 in adequately screened women, even with new sexual partners 4
  • Confirm hypertension diagnosis outside the office before treatment to avoid white-coat hypertension misdiagnosis 1
  • All positive stool-based colorectal cancer tests require colonoscopy follow-up—they are not diagnostic 1
  • Screening decisions after age 75 should be based on life expectancy ≥10 years, not age alone 1, 4
  • Lower-income individuals and those with unstable insurance coverage have consistently lower screening rates across all services 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Routine Laboratory Screening by Age Group

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Preventative Screening Guidelines for Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Evidence‑Based Recommendations for the Annual Physical Examination of a 66‑Year‑Old Woman

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Receipt of Selected Preventive Health Services for Women and Men of Reproductive Age - United States, 2011-2013.

Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002), 2017

Research

Health Maintenance for Women of Reproductive Age.

American family physician, 2021

Related Questions

What are the guidelines for a 35-year-old female new patient presenting to a primary care clinic?
What are the recommended diagnostic screenings for a 30-year-old female with an average risk profile and no significant medical history?
What are the key health recommendations for an 18-year-old female's wellness?
What are the age criteria for a well-woman (gynecologic) exam?
What are the recommended health screenings and preventive measures for a sexually active female patient of reproductive age regarding STIs, birth control, and pregnancy planning?
What does cloudy urine from an indwelling Foley catheter signify and how should it be assessed?
In a patient taking oxcarbazepine 1500 mg daily (CYP3A4 inducer) and fluoxetine 40 mg daily (CYP2D6 inhibitor), will a 30 mg dose of aripiprazole produce the same clinical effect as 30 mg taken without those interacting drugs?
How should I test for lupus anticoagulant (LA) in a patient with an unexplained prolonged activated partial thromboplastin time (aPTT)?
What interventions are recommended for a 3‑year‑old child with autism who has recently begun to imitate actions?
A patient has a prolonged Kaolin clotting time; what does this indicate, how should I confirm a lupus anticoagulant, and what are the appropriate follow‑up investigations and management?
Will a 30 mg dose of aripiprazole taken with oxcarbazepine 1500 mg daily (a strong CYP3A4 inducer) and fluoxetine 40 mg daily (a strong CYP2D6 inhibitor) produce the same clinical effect as a 15 mg dose of aripiprazole alone?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.